Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Objective response rate targets for recurrent glioblastoma clinical trials

    Objective response rate targets for recurrent glioblastoma clinical trials

    FromNeuro-Oncology: The Podcast

    Start listeningView podcast show

    Objective response rate targets for recurrent glioblastoma clinical trials

    FromNeuro-Oncology: The Podcast

    ratings:
    Length:
    32 minutes
    Released:
    Mar 17, 2023
    Format:
    Podcast episode

    Description

    Dr. Maya Graham interviews Drs. Benjamin Ellingston and Timothy Cloughesy about their recently published manuscript entitled: "Objective response rate (ORR) targets for recurrent glioblastoma clinical trials based on the historic association between ORR and median overall survival", published online in Neuro-Oncology in January 2023.   Read Paper
    Released:
    Mar 17, 2023
    Format:
    Podcast episode

    Titles in the series (79)

    Neuro-Oncology: The Podcast will keep you up to date about the latest advances in the field as we present conversations with the authors of selected papers from Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances.